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Abstract
Polypharmacy in older adults is a growing problem, as some drugs may be either unnecessary or even harmful. Admission to
hospital under a Medicine for the Elderly specialist physicians represents an opportunity to review patients’ medication. The
recent introduction of electronic prescribing to some hospitals in the United Kingdom allows the development of tools to measure
polypharmacy in in-patients, and subsequently to assess the efficacy of interventions that aim to optimize medication prescribing.
We tested the feasibility of developing an Excel-based software code that measured the number ofmedications a group of patients
were taking at admission and how many of these were still prescribed on discharge. Electronic prescribing data was obtained
from the Royal Derby Hospital, over a period of 52 weeks fromApril 2017 toMarch 2018 for all patients over the age of 65 years
who were admitted onto the medicine for the elderly wards and subsequently discharged. On admission, the median number of
eligible medications was 11 (interquartile range IQR 8 to 15). At the time of discharge, the median number of eligible medications
retained since admission was 9 (IQR 6 to 12). This represents a median number of medications that have been removed from the
current medication regimen of 2 (IQR 1 to 3, p < 0.001). Electronic prescribing software in hospitals allows the development of
tools to measure the burden of medications, and to examine the efficacy of future interventions that are developed to optimize
drug prescribing in older adults.
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1 Introduction
The demographic profile of countries in Western Europe and
Japan is changing as a consequence of longer life expectancy,
which results in more elderly population living for longer,
often with multiple co-morbidities [1]. Physicians caring for
these patients recognize that as a consequence of these
diseases, in conjunction often with multiple healthcare epi-
sodes with different clinicians, the total number of medica-
tions can increase to a level where some of the medications
are of minimal benefit to the patient, or even counterproduc-
tive to their well-being as side-effects and interactions be-
tween medications occur in a relatively vulnerable population.
The accumulation of multiple medications has been termed
‘polypharmacy’ [2] and contact with a physician with special-
ist expertise in the complexity of caring for older adults during
an acute hospital admission represents a unique opportunity to
discuss treatment priorities and review these medicines and
ensure that the patient is only on those which are currently
required.
The problem of polypharmacy has been recognized for
decades in primary care, and this has led to a wide range of
epidemiological and clinical studies based in this setting that
aim to quantify and also address this issue (ref). These have
been enabled by the availability of electronic patient databases
in primary care that often include medications, which permits
targeting specific medications and also quantifying the total
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individual burden of medication. Hospital doctors who care
for the elderly are also very aware of the risks of
polypharmacy in their patient population, but until very re-
cently they have had to rely on individual clinical review of
patients’ medication as hospitals generally used paper drug
records. However, as electronic prescribing software is now
becoming available in UK (and other countries) hospitals, this
allows the development of software tools that can quantify the
scale of the problem of polypharmacy and the efficacy of
interventions designed to address it at the institutional level
for the first time.
The introduction of electronic prescribing software in sec-
ondary care is generally driven by an aim to improve the
safety and efficiency of prescribing and delivering medica-
tions to patients. However, it also provides the opportunity
to measure the burden of medications at the time of admission
to hospital, and subsequently when the patient is discharged,
thus allowing assessment of how this has changed during the
course of the hospital episode. This is particularly important in
the medical care of elderly patients, whose doctors are trained
to use hospital admissions as an opportunity of review the
appropriateness of all medications. We have used electronic
prescribing software to quantify the polypharmacy burden,
and how it has changed during the course of admission under
the Medicine for the Elderly speciality wards at a busy UK
teaching hospital as part of an initial feasibility study. This can
subsequently be used to develop appropriate interventions that
target polypharmacy in this population.
2 Methodology
2.1 Study population
Electronic prescribing data was obtained from the Royal
Derby Hospital, a busy acute teaching hospital in the UK, over
a period of 52 weeks from April 2017 to March 2018 of all
patients over the age of 65 years who were admitted onto the
specialist Medical Care for the Elderly wards and subsequent-
ly discharged from the hospital. This was a feasibility study to
text the hypothesis that it was possible to quantify the burden
of polypharmacy in an elderly in patient population using
electronic prescribing software.
2.2 Prescribing data
The main outcome of interest was the number of drugs that a
patient was prescribed: firstly, at the time of admission to
hospital; and secondly, how many of these medications were
prescribed at the time of discharge from hospital. The data
were obtained from the prescribing software system (iCM,
Isoft) for all eligible individuals.
2.3 Generation of polypharmacy software tool
Once the anonymized medication data for all eligible patients
was downloaded from the prescribing software system (iCM,
Isoft) for all eligible individuals at admission and discharge,
these were imported into a SQL database. As a consequence
of oral corticosteroids, antibiotics and nebulized medications
sometimes being continued for a short period after discharge,
these were excluded from all analyses, as these were likely to
not reflect the longer term impact of the total burden of med-
ications after discharge. The main data analysis was done
using SQL, Excel, and Stata. The SQL code is provided as
an appendix (Appendix) permitting replication of the data
extraction and cleaning. In brief, the software provided a
count of the number of medications at admission firstly, and
how many of these medications were prescribed at the time of
discharge from hospital after exclusion of oral corticosteroids,
antibiotics and nebulized medications.
2.4 Data analysis
The admission medications were used to generate a count of
the number of medications that a patient was admitted on. A
similar approach was used for the number of medications that
were retained until the time of discharge. These were used to
generate summary statistics of the median number and range
of the total number of medications of interest, and the differ-
ences between these two groups analysed using the Wilcoxon
signed rank test (Stata statistical software). The validity of the
electronic prescribing data was cross checked with medical
and pharmacy staff to ensure the integrity of the data.
3 Results
Data were available on 3454 admission episodes. The median
age of the study population was 86 years (interquartile range
80 to 91).
On admission, the median number of eligible medications
was 11 (interquartile range IQR: 8 to 15), with the proportion
of patients having been prescribed five or more and ten or
more eligible medications being 94% and 64% respectively
(Fig. 1). At the time of discharge, the median number of eli-
gible medications retained since admission was 9 (IQR 6 to
12), with the proportion of patients having been prescribed
five or more and ten or more eligible medications being
88% and 46% respectively (Fig. 1). This represents a median
number of medications that have been removed from the cur-
rent medication regimen of 2 (IQR 1 to 3, p < 0.001,Wilcoxon
signed rank test). The distribution of the change in medica-
tions is presented in Fig. 2.
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4 Discussion
We have used electronic prescribing system data describe the
number of medications that elderly patients admitted to a busy
acute teaching hospital are taking, and how this decreases after
discharge from hospital under the care of a physician with a
specialist interest in Medical Care of the Elderly. This soft-
ware is relatively new to secondary care in the United
Kingdom, and provides a novel tool that can help support
clinicians caring for this patient group to audit trends in
polypharmacy over time, assess effectiveness of interventions
that aim to target polypharmacy, as well as facilitating the
targeting of specific drugs that may be considered inappropri-
ate for this population.
The strengths of the analysis include the confidence that we
have captured data in 100% of eligible patient episodes as a
consequence of the inclusiveness of the electronic prescribing
software. This was a feasibility study designed to demonstrate
the proof-of-concept that electronic prescribing systems can
be used to measure the burden of polypharmacy in an elderly
inpatient population. As a consequence, it was delivered in a
single centre, and the data presented are not necessarily gen-
eralizable to other centres where patient demographics and
medical practice may vary. The limitations are that it is essen-
tially an epidemiological tool that can observe and describe
the activity of the secondary care doctors, but does not permit
correlation with the clinical condition that necessitates pre-
scribing of medications, and hence cannot allow evaluation
of how appropriate the prescribing of these medications is.
This is inevitable, as the responsibility for prescribing is with
the attending physician. It is important to acknowledge that
the term ‘polypharmacy’ is descriptive, and not judgmental,
and is used in this analysis as a summary statistic for the total
medication burden. As we wished to demonstrate that elec-
tronic prescribing has the potential to quantify the number of
medications, we excluded new medications that were started
in hospital from the analysis. Hence, some of the observed
decrease will be a consequence of the substitution of new
medications for existing ones, as part of the clinical treatment.
The current data and analysis demonstrate that it is feasible to
measure change in polypharmacy burden in an elderly inpa-
tient population using electronic prescribing software, and
hence future analyses will aim to proceed to determine what
are the changes in medication, are they evidence-based or not
and can this approach be used to systematically introduce and
assess institution-based interventions to rationalize patient
medication and improve patient care? The software code is
provided in the appendix in the SQL format as this is a com-
monly used database that can be used by any interested re-
searchers, and adapted to local circumstances as necessary.
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Fig. 2 Number of drugs
prescribed prior to arrival but not
on discharge
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Fig. 1 Number of drugs
prescribed on admission and the
number of these medications
prescribed at time of discharge
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Polypharmacy is well recognized as a concern in caring for
older adult patients [3], and there have been many initiatives
to try and address this. These vary from targeting the educa-
tion of doctors and associated healthcare professionals to in-
crease awareness of these issues to drug reviews of the appro-
priateness of medications in elderly populations by pharma-
cists [4]. Although polypharmacy has been described previ-
ously using electronic primary care prescribing databases [1],
this approach has not been systemically used in secondary
care in the UK. The observation that the median number of
medications decreases by two drugs during the course of a
medical admission demonstrates that Medical Care of the
Elderly physicians are effective at reviewing medications,
and the scale of the decrease is plausible and consistent with
clinical expectations.
The implication of this analysis is that electronic prescrib-
ing software can be used to develop a tool to audit efficacy of
decreasing polypharmacy in an elderly population of second-
ary care patients. We have added the SQL code to this manu-
script as an appendix, so that interested individuals with ac-
cess to comparable electronic prescribing software data can
use this tool freely. In the future it could be used to initiate a
review of drugs which may be causing risks to patients’
wellbeing. One example would be quinine, which has been
commonly used in the past as a symptomatic treatment for leg
cramps, but has also been associated with increased mortality
rates in more recent randomized controlled trials [5].
Ultimately, it would be optimal to work towards electronic
prescribing software that covers both primary and secondary
heathcare sectors, as this would provide a longitudinal per-
spective of temporal changes in medication burden in the el-
derly, and how primary and secondary care interact to modify
this.
5 Conclusion
In conclusion, electronic prescribing systems can be used to
quantify polypharmacy in an elderly population, and to assess
the overall efficacy of specialist physicians caring for older
adult patients to address this issue during admission to hospi-
tal. Our software code is available in the Appendix for insti-
tutions that wish to replicate and build on our work. Over time,
this approach has the potential to provide an epidemiological
tool to help support doctors who care for older adults in the
context of increasing demand.
Funding information The Health Foundation Advancing Applied
Analytics Programme.
Compliance with ethical standards
Conflict of interest The authors declare that they have no conflict of
interest.
Ethical approval The study was an evaluation of the development of a
health service development and was registered as an audit using
anonymised data.
Open Access This article is licensed under a Creative Commons
Attribution 4.0 International License, which permits use, sharing,
adaptation, distribution and reproduction in any medium or format, as
long as you give appropriate credit to the original author(s) and the
source, provide a link to the Creative Commons licence, and indicate if
changes weremade. The images or other third party material in this article
are included in the article's Creative Commons licence, unless indicated
otherwise in a credit line to the material. If material is not included in the
article's Creative Commons licence and your intended use is not
permitted by statutory regulation or exceeds the permitted use, you will
need to obtain permission directly from the copyright holder. To view a
copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
References
1. Duerden M, Avery T, Payne R. Polypharmacy and medicines opti-
misation. Making it safe and sound. The Kings Fund. 2013: https://
www.kingsfund.org.uk/sites/default/files/field/field_publication_
file/polypharmacy-and-medicines-optimisation-kingsfund-nov13.
pdf. Accessed 1/3/2019.
2. Masnoon N, Shakib S, Kalisch-Ellett L, Caughey G. What is
polypharmacy? A systematic review of definitions. BMC Geriatr.
2017;17:230. https://doi.org/10.1186/s12877-017-0621-2.
3. Spinewine A, Schmader K, Barber N, Hughes C, Lapane K, Swine
C, et al. Appropriate prescribing in elderly people: how well can it be
measured and optimised? Lancet. 2007;370:173–84.
4. Payne R, Avery A. Polypharmacy: One of the greatest prescribing
challenges in general practice. Brit J General Practice. 2011:83–4.
5. Fardet L, Nazareth I, Petersen I. Association between long-term qui-
nine exposure and all-cause mortality. JAMA. 2017;317:1907–9.
Publisher’s note Springer Nature remains neutral with regard to jurisdic-
tional claims in published maps and institutional affiliations.
Health Technol.
